Angiosarcoma is considered incurable, it never responds to chemo or radiation and surgery just spreads it. An honest oncologist will admit they have absolutely nothing to help this, so if an oncologist has recommended any conventional treatment demand they show you at least three scientific studies showing benefit from the treatment they are recommending.
Angiosarcoma is quite rare, so we have only treated one case of it to date. In this case it was caused by surgery to remove a breast, which is a barbaric protocol that provides no long term survival benefit.
The patient in question had gone to FUDA hospital in China for what is called SPDT (sonophotodynamic therapy). This treatment does not work, as this patient found out.
That treatment was a stunning success, never seen before, but at that time we were only using about 5% of the power we have available now, and we did not have the very powerful adjuvants we now have at our disposal.
Angiosarcoma needs a lot of energy, so glycolysis is very important to it. Glycolysis is how cancer feeds itself.
The first PDF below discusses something called bromopyruvate. This chemical makes it impossible for the cancer to feed itself.
You've probably heard of glycolysis, the conversion of sugar to energy through fermentation. That is how cancer produces adenosine triphosphate (ATP) which is the basic food for the entire body. This molecule interferes with that, so it stops the cancer's energy production so there is no more replication and eventually the cells just die of starvation.
This has a stunning effect on cancer, but as used below it is unstable and has limited applications. In order to make it really useful we had to go beyond the current level of research and design a new molecule.
We have been using a highly modified version of this for over a year and see incredible results on all cancers. Even so, there is always room for improvement so I recently designed an even more powerful molecule, about 400 Times as powerful as anything else in the world.
This will make our angiosarcoma treatment much more powerful than what we had before.
To give you an idea of how much we have improved our treatment, the before and after pictures below are after 40 hours of treatment just using the drinks we developed for preparing a patient for the actual PDT.
The pictures on the left were takin a few weeks before the patient arrived so it would have grown somewhat. Angiosarcoma grows in sheets, and the colored segments in the scans are areas of high blood flow, so all of the colored areas on the left are Angiosarcoma. In the scan taken after only 2 days of pretreatment, the large sheets are gone and the colored area is reduced dramatically. I would say we killed 90% of this supposedly unstoppable cancer in 2 days. Off to a very good start. The leg this is growing in reduced in diameter by 7 millimeters overnight and the patient has recovered her appetite, always a good sign with cancer patients.
The next PDF file below discusses something called chitosan nanoparticles. These are made from food substances, chitosan is in yghurt and icecream to improve consistency, and the other chemical used is a harmless meat preservative. Again, this has an incredible effect on all cancer but was originally studied in liver cancer.
We have been using this for 4 years now, it has zero side effects but kills cancer like crazy. This had a very strong kill rate against cancer but we have heavily modified the formula to give an eight times improvement.
Because Angiosarcoma is in blood vessels, our chitosan nanoparticles have direct access to it, which is another advantage we did not have the first time we treated angiosarcoma.
In the pdf below you can see before and after pictures and get comparisons of kill rates with this molecule alone as compared to chemo.
|If you are doing research there are over 1,000 technical papers here|
Use the links below for an educational series on fourth generation PDT
PDT 1 PDT 2 PDT 3 PDT 4 PDT 5 PDT 6 PDT 7 PDT 8 PDT 9 PDT 10 PDT 11 Dr Garcia discussing treatmen with PDT in Cebu Interview with Osteosarcoma patient Interview with prostate cancer patient Interview with lung cancer patient with brain and bone mets